Evidence map›Paper›PMID 40883600›Full record

ArticleEye (London, England)2025

Ocular toxicities associated with MEK/BRAF inhibitors: assessing the accuracy and completeness of large language models.

Nila Kirupaharan, Camellia Edalat, Lauren A Dalvin, Kapil Mishra, Rayna Marshall, Hannah Xu, Jasmine H Francis, Meghan Berkenstock

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Eye (London, England), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nila KirupaharanThe Drexel University College of Medicine, Philadelphia, PA, USA.
Camellia EdalatThe Drexel University College of Medicine, Philadelphia, PA, USA.ORCID http://orcid.org/0009-0008-9016-7272
Lauren A DalvinDepartment of Ophthalmology, Mayo Clinic, Rochester, MN, USA.ORCID http://orcid.org/0000-0001-9710-4284
Kapil MishraGavin Herbert Eye Institute, University of California, Irvine, CA, USA.
Rayna MarshallThe Drexel University College of Medicine, Philadelphia, PA, USA.ORCID http://orcid.org/0000-0002-6961-1278
Hannah XuUniversity of California San Diego, San Diego, CA, USA.
Jasmine H FrancisMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Meghan BerkenstockThe Wilmer Eye Institute, Division of Ocular Immunology, the Johns Hopkins University School of Medicine, Baltimore, MD, USA. mberken2@jhmi.edu.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Institutional Career Development CoreKL2TR002379 · NCATS · MAYO CLINIC ROCHESTER · PI NILUFER ERTEKIN-TANER · 2017 to 2026
$14.9M
NCATS NIH HHS KL2 TR002379NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID40883600
PMCPMC12583561

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.